Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference IMAC Holdings, Inc. Mon, Feb 24, 2025, 8:15 AM 3 min read ...
The National Comprehensive Cancer Network Oncology Research Program awards funding to researchers from Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback